Fig 1: Receiver operating characteristic curve analysis for prediction of ruptured abdominal aortic aneurysm based on the MMP9 expression and aortic maximum diameter
Fig 2: Dual-luciferase experiment to explore the mechanism of HIF-1a's direct activation of MMP-9 at the transcription level.
Fig 3: Changes in DNA levels of HIF-1a, MMP-9, claudin-5, and ZO-1 RT-PCR detected the effect of TNFa and TNFa combined with different concentrations of 2ME2 on the expression of HIF-1a (a), MMP-9 (b), claudin-5 (c), and ZO-1 (d) DNA levels. *P < 0.05; **P < 0.01; ns, no significant difference (no significance).
Fig 4: Post-extraction correlation of HbA1c with salivary markers (OPG, RANKL, OPG/RANKL, HGF, TNF-a, MMP-9, IL-18, TOS and TAC).
Fig 5: Calibration plots of (A) MMP-9 and (B) TNF-a biomarkers, respectively (black circle data points). Red square data points indicate the detection of indicated spiked concentrations of (A) MMP-9 and (B) TNF-a biomarkers from the simulated serum samples using respective calibration plots.
Supplier Page from Abcam for Human MMP9 ELISA Kit